Skip to main content

Kyle Nixon

Analyst

Canaccord Genuity

Equibles does not estimate personal net worth.

About Kyle Nixon

Kyle Nixon is recorded as Analyst at Canaccord Genuity. Kyle Nixon has spoken on 3 earnings calls across 3 companies, most recently for Quantum-Si Inc on August 13, 2026. Those appearances were for Quantum-Si Inc (QSI), Veracyte, Inc. (VCYT) and 10x Genomics, Inc. (TXG). The companies whose calls Kyle Nixon spoke on are classified in the Healthcare sector.

Kyle Nixon on recent calls

“On the additional cycle that you're, I guess, working on, can you maybe speak to how performance or reproducibility could be affected by this? Or maybe, you know, maybe the steps that you take to avoid maybe impacting what your, you know, prior performance level expectations were going to be?”
Analyst — Canaccord Genuity, Quantum-Si Inc Q2 FY2026 Earnings Call ·
“I think Rebecca, in response to Sibu's question, you parsed out Affirma and Decipher expectations for the year with respect to revenue. I think you said mid-single-digit, high-single-digit for Affirma, and then Decipher 20% growth you kind of left.”
Analyst — Canaccord Genuity, Veracyte, Inc. Q4 FY2025 Earnings Call ·
“And secondly, just on the IP side, PTAB invalidated all your claims asserted against a single cell competitor's products. Just given that litigation, is there going to be even more competitive headwinds in single cell going forward?”
Analyst — Canaccord Genuity, 10x Genomics, Inc. Q4 FY2024 Earnings Call ·

Affiliation history

  • Canaccord Genuity

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity